A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines

Wu,Jing-Jing; Sun,Wu-Yi; Hu,Shan-Shan; Zhang,Sen; Wei,Wei

doi:10.3892/ijo.2013.2085

A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines

Authors:
- Jing-Jing Wu
- Wu-Yi Sun
- Shan-Shan Hu
- Sen Zhang
- Wei Wei
View Affiliations

Affiliations: Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education, Engineering Technology Research Center of Anti-inflammatory and Immunodrugs in Anhui Province, Hefei, Anhui 230032, P.R. China
Published online on: August 30, 2013 https://doi.org/10.3892/ijo.2013.2085
Pages: 1643-1651

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Paeonia lactiflora and Astragalus membranaceus are two traditional Chinese medicines, which are commonly used in Chinese herb prescription to treat liver diseases. The protective effects of the extract prepared from the roots of Paeonia lactiflora and Astragalus membranaceus (PAE) on liver fibrosis have been demonstrated in previous studies. However, its effect on hepatocellular carcinoma (HCC) has not been investigated to date. In this study, the effects of PAE on the apoptosis, proliferation, migration and invasion of the human hepatoma cell lines HepG2 and SMMC-7721 were investigated. Our data demonstrated that treatment with PAE (50-200 mg/l) caused an inhibitory effect on the proliferation of the hepatoma cell lines HepG2 and SMMC-7721. Furthermore, PAE induced apoptosis of HepG2 cells and SMMC-7721 cells, which was demonstrated by PI staining. In addition, immunocytochemistry and western blotting showed that PAE significantly decreased the expression of Bcl-2, while the expression of Bax and cleaved caspase-3 in HepG2 cells and SMMC-7721 cells was significantly increased after treatment with PAE. These results clearly demonstrated that PAE induced hepatoma cell apoptosis through increasing the Bax-to-Bcl-2 ratio and upregulating the activation of caspase-3. In addition, the results of wound healing assay and Matrigel invasion assay showed that PAE displayed inhibitory activity on the migration and invasion of HCC cells. Taken together, the present data provides evidence that PAE is a potent antineoplastic drug candidate for the treatment of HCC.

View Figures

View References

1.	El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
2.	Yang JD and Roberts LR: Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458. 2010. View Article : Google Scholar : PubMed/NCBI
3.	He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med. 353:1124–1134. 2005. View Article : Google Scholar : PubMed/NCBI
4.	Villanueva A and Llovet JM: Targeted therapies for hepatocellular carcinoma. Gastroenterology. 140:1410–1426. 2011. View Article : Google Scholar : PubMed/NCBI
5.	Ma L, Wen S, Zhan Y, He Y, Liu X and Jiang J: Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med. 74:245–251. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Wang S, Zheng Z, Weng Y, et al: Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci. 74:2467–2478. 2004. View Article : Google Scholar : PubMed/NCBI
7.	Dai LM, Chen MZ and Xu SY: Protective effects of total glucocides of paeony on experimental hepatitis. Chinese Pharmacol Bull. 9:449–453. 1993.
8.	Wang H, Wei W, Wang NP, et al: Effects of total glucosides of peony on immunological hepatic fibrosis in rats. World J Gastroenterol. 11:2124–2129. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Zheng YQ and Wei W: Total glucosides of paeony suppresses adjuvant arthritis in rats and intervenes cytokine-signaling between different types of synoviocytes. Int Immunopharmacol. 5:1560–1573. 2005. View Article : Google Scholar : PubMed/NCBI
10.	Wang SH, Wei W, Xu DJ and Cui Y: Proliferation inhibition and mechanism of TGP on HepG2 cell in vitro. Acta Universitatis Medicinalis Anhui. 41:547–549. 2006.
11.	Wang SH, Wei W, Xu DJ, Xu SP and Cui Y: Proliferation inhibition of TGP on SMMC-7721 Cell in vitro. Anhui Med Pharmaceut J. 10:8–9. 2006.
12.	Zhang L and Zhang S: Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells. Phytother Res. 25:1551–1557. 2011. View Article : Google Scholar : PubMed/NCBI
13.	Wu H, Li W, Wang T, Shu Y and Liu P: Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Biomed Pharmacother. 62:659–666. 2008. View Article : Google Scholar
14.	Tsuboi H, Hossain K, Akhand AA, et al: Paeoniflorin induces apoptosis of lymphocytes through a redox-linked mechanism. J Cell Biochem. 93:162–172. 2004. View Article : Google Scholar : PubMed/NCBI
15.	Zhang Q, Gao WY and Man SL: Chemical composition and pharmacological activities of astragali radix. Zhongguo Zhong Yao Za Zhi. 37:3203–3207. 2012.(In Chinese).
16.	Law PC, Auyeung KK, Chan LY and Ko JK: Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. BMC Complement Altern Med. 12:1602012. View Article : Google Scholar
17.	Hu XY, Xia RX, Cheng CB, et al: Mechanism of apoptosis in human leukemia NB4 cells induced by total astragalosides. Zhonghua Zhong Liu Za Zhi. 33:345–348. 2011.(In Chinese).
18.	Liu X, Yang Y, Zhang X, et al: Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell. J Gastroenterol Hepatol. 25:420–426. 2010.
19.	Nishiyama N, Wang YL and Saito H: Beneficial effects of S-113m, a novel herbal prescription, on learning impairment model in mice. Biol Pharm Bull. 18:1498–1503. 1995. View Article : Google Scholar : PubMed/NCBI
20.	Sun WY, Wei W, Wu L, Gui SY and Wang H: Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol. 112:514–523. 2007.PubMed/NCBI
21.	Shao FR, Wei W, Liu H, et al: Comparison of protective effect of Shaoqiduogan extracted by different methods on immunological liver injury in mice. J Anhui TCM College. 26:21–24. 2007.
22.	Sun WY, Wei W, Gui SY, Wu L and Wang H: Protective effect of extract from Paeonia lactiflora and Astragalus membranaceus against liver injury induced by bacillus Calmette-Guerin and lipopolysaccharide in mice. Basic Clin Pharmacol Toxicol. 103:143–149. 2008.
23.	Colombo M, de Franchis R, Del Ninno E, et al: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:675–680. 1991. View Article : Google Scholar : PubMed/NCBI
24.	Paradis V: Histopathology of hepatocellular carcinoma. Recent Results Cancer Res. 190:21–32. 2013. View Article : Google Scholar : PubMed/NCBI
25.	Zhang XY and Wang J: A study on the chemical constituents of Paeonia lactiflora Pall. J Shenyang Pharmaceutl Univ. 18:30–32. 2001.
26.	Rahbari NN, Mehrabi A, Mollberg NM, et al: Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg. 253:453–469. 2011. View Article : Google Scholar : PubMed/NCBI
27.	Alves RC, Alves D, Guz B, et al: Advanced hepatocellular carcinoma. Review of targeted molecular drugs Ann Hepatol. 10:21–27. 2011.
28.	Yu YL, Lu Y, Tang X and Cui FD: Formulation, preparation and evaluation of an intravenous emulsion containing Brucea javanica oil and Coix Seed oil for antitumor application. Biol Pharm Bull. 31:673–680. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Li WY, Chiu LC, Lam WS, et al: Ethyl acetate extract of Chinese medicinal herb Sarcandra glabra induces growth inhibition on human leukemic HL-60 cells, associated with cell cycle arrest and up-regulation of pro-apoptotic Bax/Bcl-2 ratio. Oncol Rep. 17:425–431. 2007.PubMed/NCBI
30.	Luqman S and Pezzuto JM: NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res. 24:949–963. 2010.PubMed/NCBI
31.	Karikas GA: Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. J BUON. 15:627–638. 2010.PubMed/NCBI
32.	You N, Liu W, Wang T, et al: Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo. Oncol Rep. 28:2091–2100. 2012.PubMed/NCBI
33.	Hu S, Sun W, Wei W, et al: Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis. Anticancer Drugs. 24:140–149. 2013. View Article : Google Scholar : PubMed/NCBI
34.	Sun WY, Wang L, Liu H, Li X and Wei W: A standardized extract from Paeonia lactiflora and Astragalus membranaceus attenuates liver fibrosis induced by porcine serum in rats. Int J Mol Med. 29:491–498. 2012.
35.	Thompson HJ, Strange R and Schedin PJ: Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev. 1:597–602. 1992.PubMed/NCBI
36.	Giannattasio A, Angeletti G, De Rosa M, et al: RNA expression bcl-w, a new related protein Bcl-2 family and caspase-3 in isolated sertoli cells from pre-pubertal rat testes. J Endocrinol Invest. 25:C23–C25. 2002. View Article : Google Scholar : PubMed/NCBI
37.	Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322–1326. 1998. View Article : Google Scholar : PubMed/NCBI
38.	Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2:647–656. 2002. View Article : Google Scholar : PubMed/NCBI
39.	Barille-Nion S, Bah N, Vequaud E and Juin P: Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy. Anticancer Res. 32:4225–4233. 2012.PubMed/NCBI
40.	Zeng H, Kong X, Peng H, et al: Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 16:711–727. 2012.PubMed/NCBI
41.	Kinoshita M, Eguchi Y and Hynynen K: Activation of Bak in ultrasound-induced, JNK- and p38-independent apoptosis and its inhibition by Bcl-2. Biochem Biophys Res Commun. 353:515–521. 2007. View Article : Google Scholar : PubMed/NCBI
42.	Galluzzi L, Kepp O and Kroemer G: Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy. Oncogene. 31:2805–2808. 2012. View Article : Google Scholar : PubMed/NCBI
43.	Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI
44.	Zhu S, Cohen MB, Bjorge JD, Mier JW and Cho DC: PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells. J Cell Mol Med. 17:377–385. 2013. View Article : Google Scholar : PubMed/NCBI
45.	Lin HI, Lee YJ, Chen BF, et al: Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Lett. 230:248–259. 2005. View Article : Google Scholar : PubMed/NCBI
46.	Tao YM, Liu Z and Liu HL: Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma. Dig Liver Dis. 45:251–257. 2013. View Article : Google Scholar : PubMed/NCBI
47.	Korpi JT, Hagstrom J, Lehtonen N, et al: Expression of matrix metalloproteinases-2, -8, -13, -26 and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol. 20:e18–e22. 2011. View Article : Google Scholar : PubMed/NCBI